Quantcast

Latest Papillomavirus Stories

2014-07-23 08:32:38

Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18. Treatment...

2014-07-15 12:42:23

St. Michael's Hospital Ontario spent nearly $110 million dollars between 2006 and 2010 on bonuses to motivate family doctors to screen more of their patients for cancer but these bonuses were associated with little or no improvement in actual cancer screening rates, according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study, published today in Annals of Family Medicine, tracked screening rates for cervical, breast and...

2014-07-08 16:25:46

ATLANTA, July 8, 2014 /PRNewswire/ -- Femasys Inc., an emerging medical device developer of women's healthcare solutions, announced today that it has entered into a nationwide distribution agreement with McKesson Medical-Surgical to sell and distribute Femasys' FEMCERV® Endocervical Sampler. FEMCERV collects a tissue sample of a woman's endocervical canal for histological analysis when cervical cancer is suspected. Under terms of the agreement, McKesson Medical-Surgical will sell...

2014-07-01 10:02:49

American College of Physicians ACP's new evidence-based guideline finds that harms of screening pelvic examination outweigh any demonstrated benefits Many women and physicians believe that a pelvic examination should be part of annual well visits, but an analysis of the current evidence by the American College of Physicians (ACP) shows that the harms outweigh any demonstrated benefits. ACP's new evidence-based clinical practice guideline, "Screening Pelvic Examination in Adult...

2014-06-23 04:20:45

Inovio's Immunotherapy will Treat Women with Inoperable HPV-caused Cancer BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival of its DNA immunotherapy product, INO-3112, in treating human papillomavirus (HPV)-associated cervical cancer. INO-3112 is a combination of Inovio's lead active immunotherapy...

2014-06-17 23:02:39

New research report “Human Papillomavirus Infections Vaccine Pipeline Analysis” drawn up by PNS Pharma is available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Human papillomaviruses represent a group of over 150 viruses which are related to each other, with certain types of viruses being able to cause warts (papillomas). There exist only two human papillomavirus vaccines which are currently marketed worldwide. Both these vaccines are prepared with the use of the...

2014-06-11 08:30:52

Inovio Responds to False and Misleading Speculation Regarding Immunotherapy Study BLUE BELL, Pa., June 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) wishes to clarify that a third party article published on June 10, 2014, was misrepresentative of facts and can only be taken as malicious. The referenced article does not reflect the progress, status, and potential of Inovio's active immune therapy technology and products and is rife with false and misleading...

2014-06-10 23:14:19

Christopher Shaw, PhD, a funded researcher by Children’s Medical Safety Research Institute (CMSRI), was mentioned in the Huffington Post for his stance regarding the cervical cancer vaccine. Fairfax, VA (PRWEB) June 10, 2014 Christopher Shaw, PhD, a scientific advisory board member of Children’s Medical Safety Research Institute (CMSRI), founded by Claire Dwoskin of the Dwoskin Family Foundation, was featured in Huffington Post, defending his stance regarding the cervical cancer...

2014-06-10 16:26:58

LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. Roche has also launched the fully automated CINtec® PLUS test to improve the detection and early intervention of pre-cancerous cervical disease. The Health Canada approved CINtec® PLUS cytology test helps identify women with high-grade pre-cancerous cervical...

2014-06-10 12:30:44

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/treatments/human_papillomavirus_hpv_associated_cancer_pipeline_review_h1_2013.html Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Direct's, 'Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014', provides an...


Latest Papillomavirus Reference Libraries

Colposcopy
2013-01-18 11:34:29

The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual...

Colposcopy
2012-12-31 11:42:30

The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual assault...

45_00e375d98757db4f63a2a3730ff3f4e9
2011-02-22 18:15:54

The cottontail rabbit papilloma virus (CRPV), is a type I virus under the Baltimore scheme and posses a non-segmented dsDNA genome. It infects rabbits by causing keratinous carcinomas usually near the animal's head. These tumors eventually interfere with the host's ability to eat and can lead to starvation. The virus provided the first mammalian model of a cancer caused by a virus. The name comes from Dr. Richard E. Shope, who discovered it in the 1930s. Shope isolated virus particles from...

70_b8b62a52cfe7738ea493589083a1b7aa
2011-02-17 17:39:05

Papillomaviridae is a taxonomic family of non-enveloped DNA viruses, collectively known as papillomaviruses. There are several hundred species, or types, of papillomaviruses that have been identified. Most infections are asymptomatic or cause small benign tumors. Types 16 and 18 carry risks of becoming cancerous. They replicate in the basal layer of the body surface tissues. Typically they infect the skin but can infect a particular body surface. HPV type 1 tends to infect the soles of...

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (6 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related